Your browser doesn't support javascript.
loading
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.
Salit, Rachel B; Fowler, Daniel H; Wilson, Wyndham H; Dean, Robert M; Pavletic, Steven Z; Dunleavy, Kieron; Hakim, Frances; Fry, Terry J; Steinberg, Seth M; Hughes, Thomas E; Odom, Jeanne; Bryant, Kelly; Gress, Ronald E; Bishop, Michael R.
Affiliation
  • Salit RB; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
J Clin Oncol ; 30(8): 830-6, 2012 Mar 10.
Article in En | MEDLINE | ID: mdl-22312100
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Hematopoietic Stem Cell Transplantation / Lymphoma Language: En Journal: J Clin Oncol Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Hematopoietic Stem Cell Transplantation / Lymphoma Language: En Journal: J Clin Oncol Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States